Technické konopí (Cannabis sativa L.) jako možný zdroj kanabidiolu by Jana PEXOVÁ KALINOVÁ et al.
Industrial hemp (Cannabis sativa L.) as a possible source of cannabidiol
Jana PEXOVÁ KALINOVÁ1 (✉), Naděžda VRCHOTOVÁ2, Jan TŘÍSKA2, Šárka HELLEROVÁ1
Technické konopí (Cannabis sativa L.) jako možný zdroj kanabidiolu
1 Faculty of Agriculture, University of South Bohemia, Studentská 1668, České Budějovice 370 05, Czech Republic
2 Laboratory of Metabolomics and Isotopic Analyses, Global Change Research Institute, Academy of Sciences of the 
Czech Republic, Lipová 9, České Budějovice 370 05, Czech Republic
✉ Corresponding author: janak@zf.jcu.cz
ABSTRACT
(-)-Cannabidiol (CBD) is a cannabinoid, which has unique pharmacological and biological activities.The aim of this 
study was to determine the CBD, cannabidiolic (CBDA), and canabigerolic acids (CBGA) content in parts of industrial 
hemp that are possible waste material in the production of hemp fiber, and could be used for CBD extraction. Two 
hemp varieties were sampled at the full-flowering stage, and at the ripening stage. The lyophilised material (leaves, 
roots, stems, and inflorescences/seeds) was extracted with ethylacetate and analyzed by HPLC. Hemp inflorescences 
and leaves are the most important source of CBD. CBDA and CBGA are the dominant compounds in these plant parts. 
They are the precursors of CBD. The CBD level is dependent on the variety and the environmental conditions. Dry cool 
weather with lower solar intensity increased the CBD level in 'Bialobrzeskie' - a monoecious variety potentially suitable 
as a material for CBD extraction with heat decarboxylation due to the high CBDA, CBGA, and CBD levels in the leaves 
and inflorescences.
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ABSTRAKT 
(-) - Kanabidiol (CBD) je kanabinoid, který má jedinečné farmakologické a biologické účinky. Cílem této práce bylo 
zjistit obsah CBD, kyseliny kanabidiolové (CBDA) a kanabigerolové (CBGA) v jednotlivých částech technického konopí, 
které jsou možným odpadovým materiálem při výrobě konopných vláken a mohly by být použity k extrakci CBD. Vzorky 
ze dvou odrůd konopí byly odebrány ve fázi plného květu a ve fázi zrání. Lyofilizovaný materiál (listy, kořeny, stonky 
a květenství / semena) byl extrahován ethylacetátem a analyzován pomocí HPLC. Konopná květenství a listy jsou 
nejdůležitějším zdrojem CBD. CBDA a CBGA jsou dominantní sloučeniny v těchto rostlinných částech. Tyto látky jsou 
prekurzory CBD. Obsah CBD závisí na odrůdě a podmínkách prostředí. Suché chladné počasí s nižší intenzitou slunečního 
záření zvýšilo hladinu CBD v rostlinách. „Bialobrzeskie“ – jednodomá odrůda je potenciálně vhodná jako materiál pro 
extrakci CBD po tepelné dekarboxylaci z důvodu vysokého obsahu CBDA, CBGA i CBD v listech a květenstvích.
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INTRODUCTION 
 (-)-Cannabidiol (CBD) is one of the main 
cannabinoid components from hemp (Cannabis sativa 
L.), which has no psychotropic effects, contrary to Δ9 - 
tetrahydrocannabinol (THC), as it does not activate the 
CB1 and CB2 cannabinoid receptors in the brain. CBD 
has sedative, antipsychotic, antiepileptic, analgesic 
effects, decreases the intraocular pressure, and also 
has antioxidant and neuroprotective properties (Zuardi, 
2008, Grotenhermen and Muhler-Vahl, 2012). The anti-
inflammatory effects of CBD in pneumococcal meningitis 
has been confirmed by Barichello et al. (2012). CBD 
also had potent anti-arthritic effects in murine collagen-
induced arthritis (Malfait et al., 2000), has reversed 
cognitive impairment in a sepsis animal model (Cassol 
at al., 2010), has decreased inflammation in a murine 
model of lung injury (Ribeiro at al., 2012), has reduced 
brain damage in a hypoxic-ischemic model (Alvarez et 
al., 2008), has acted as an antiproliferative compound, 
inducing alossin viability in various tumor cell lines 
(Yang et al., 2014), and has suppressed murine intestinal 
inflammation (Burstein and Zurier, 2009). CBD could be 
used for diabetes treatment where it can inhibit and delay 
destructive insulitis and inflammation (Weiss et al., 2006), 
and it can prevent the decrease in autophagy induced 
by alcohol because it protects mouse liver from acute 
alcohol-induced steatosis through multiple mechanisms 
including attenuation of alcohol-mediated oxidative 
stress (Yang et al., 2014).
It is possible to find CBD in all hemp species and 
varieties (varying from nearly 0 to 95% of the total 
cannabinoids). CBD has an inverse relationship with 
THC. For that reason, industrial hemp has a low THC 
content but a high CBD content (Guy et al., 2004). The 
CBD and THC contents are controlled by independent 
genes. Inheritance of the cannabinoid content is sex-
linked through the maternal line (Sytnik and Stelmah, 
1998). So, it is possible to influence the CBD content in 
hemp by selection of the chemocultivar type (type I low 
CBD content, type II and III high CBD content) (Guy et al., 
2004). Fiber hemp (C. sativa) landraces from Turkey, used 
for the fiber production, are an example of a rich source 
for pure CBD (95% proportion of total cannabinoids). 
However, the CBD and THC contents, and the ratio of 
both compounds, are also depend on environmental 
conditions (Fusar-Poli et al., 2009, Grotenhermen and 
Muhler-Vahl, 2012).
Hemp varieties with a low Δ9-THC content (and 
potentially high content of CBD or other phenolic 
compounds) could not only be used for fiber, seed, or 
energy production but could also be used for medicinal 
purposes (Guy et al., 2004).
Gas and liquid chromatography are the most commonly 
used methods for CBD determination in hemp. HPLC-
DAD was chosen because the thermal conversion of 
acidic cannabinoids that occurs in gas chromatography 
systems has been demonstrated as providing incomplete 
and non-reproducible results, this because only neutral 
forms of cannabinoids are detected (De Backer et al., 
2009).
The aim of this study was to determine the CBD, 
cannabidiolic (CBDA), and canabigerolic acids (CBGA), 
content in parts of industrial hemp that are possible 
waste material in the production of hemp fiber, and could 
be used for CBD extraction.
MATERIALS AND METHODS 
Field experiment 
Hemp (Cannabis sativa L.), varieties 'Finola' (dioecious) 
and 'Bialobrzeskie' (monoecious) were grown on plots 
(each plot 12 m2) in České Budějovice (380 m a.s.l., 
cambisol with pH 5.6) in both 2012 (average annual 
temperature 9.3 °C, average annual sum of precipitation 
799 mm) and in 2014 (average annual temperature 
10.3 °C, average annual sum of precipitation 621 mm). 
Both varieties fulfilled the 0.2% limit for THC content 
established by EU regulations (Council Regulation (EC) 
No. 1420/98), and therefore the THC level was not 
investigated. The randomized complete block design with 
three repetitions was used in the field experiment. 
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The basic meteorological data during the growing 
period are given in Table 1. The content of nutrients in the 
soil were as follows: nitrogen 17 mg/kg DM, phosphorus 
82 mg/kg DM, potassium 128 mg/kg DM, magnesium 
108 mg/kg DM, and calcium 1102 mg/kg DM in 2012; 
with nitrogen 18 mg/kg DM, phosphorus 91 mg/kg DM, 
potassium 144 mg/kg DM, magnesium 125 mg/kg DM, 
and calcium 1 056 mg/kg DM in 2014. 
In both years, seeds were sown on 22nd May by a 
machine for exact sowing in lines 25 cm wide with a 
growth density of 250 seeds per m2. During the vegetation 
period one mechanical treatment of the stands was 
performed - weeding at the stage the 5th pair of leaves 
unfolded. Unfortunately, the 'Finola' variety stand was 
destroyed by heavy rain at an early growth stage in 2014.
First, half of one plot area (6 m2) was used for sampling 
at the full-flowering stage of hemp, and the second half 
(6 m2) was sampled at the ripening stage. The number of 
plants per square meter of each plot were determined 
before plant sampling. All plants from 1 square meter 
were sampled twice from every repetition. The plant 
samples were divided into their individual parts: leaves, 
roots, stems, and inflorescences/seeds. Next, the dry 
matter of the biomass was determined by oven drying for 
2hr at 135 °C.
Sample preparation for HPLC analysis
Samples of 30 plants per plot for HPLC analysis were 
taken randomly five times (6 plants) diagonally in the 
plot at the flowering stage. The heights of the whole 
plants were also measured, and then they were divided 
into: the inflorescences (flowers with leaves without a 
petiole with small branchlets without parts of the main 
stem), stems, leaves (only green leaves with a petiole), 
and roots. Samples of the stems and inflorescences were 
taken separately from both female and male plants in 
the case of the dioecious variety 'Finola'. Leaves from 
the female and male plants were not sampled due to the 
fast withering of male plants after flowering. Individual 
plant parts were cut into approximately 1 cm lengths, 
mixed, and a representative sample of about 150g was 
immediately frozen and lyophilised (-50 °C). 
Seeds (about 100 g from every plot) were sampled at 
the stage of full maturity after the harvest by a small-plot 
combine harvester. All seed materials were immediately 
frozen and lyophilised (-50 °C). The dried material was 
stored in a freezer (-18 °C). The dry matter of individual 
plant parts were determined for an estimation of 
potential CBD production by the hemp stand on one 
hectare at sampling time. The potential CBD production 
was calculated by multiplying the mean number of plants 
per hectare by the mean CBD level in the given dry plant 
part of one plant.
The lyophilised material was grounded (Retsch 
MM200 mill), and 0.25 g of the sample was extracted 
with 3 ml of ethylacetate for 30 min in a water bath at 40 
°C. After centrifugation (1800 g for 10 min) the sediment 
was twice re-suspended in 1 mL of ethylacetate, all 
supernatants were pooled, the ethylacetate evaporated 
under a stream of nitrogen, and the residues were 
dissolved in 1 ml of methanol. 
Table 1. Meteorological data during the growing period in 2012 and 2014
Year
Mean daily air temperature (°C) Total precipitation (mm)
2012 2014 2012 2014
May 15.0 10.6 73.7 116.2
June 18.0 12.8 168.2 32.2
July 18.7 17.6 141.8 115.2
August 18.9 19.7 137.2 112.4
September 14.0 16.4 61.4 75.0
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Heating of hemp extracts due to decarboxylation 
was performed in a universal laboratory oven (UF 260, 
Memmert GmbH) at 50 °C for 180 min, and then at 145 
°C for 15 min.
HPLC analysis 
Samples were analyzed by HPLC HP 1050 (Hewlett-
Packard, U.S.A.) with a Phenomenex Luna C18 (2), 3 
µm, 2 x 150 mm column (Phenomenex, U.S.A.) and 
DAD detector G1315B. The mobile phase A was: 5% 
acetonitrile + 0.1% o-phosphoric acid; mobile phase B 
was: 80% acetonitrile + 0.1% o-phosphoric acid. 
The samples (5 μl) were measured in isocratic flow: 
17% A + 83% B for 15 min, with a flowrate of 0.25 ml/
min at 35 °C. The spectra were scanned in the range of 
190 - 600 nm during the analysis. CBD, cannabidiolic acid 
(CBDA), and cannabigerolic acid (CBGA) were determined 
by confirmation of their retention times; and the DAD 
spectra with an authentic standard. The content of CBD, 
CBGA, and CBDA in the samples were calculated from 
the calibration curve at 220 nm. Limit of detection (LOD) 
was 0.013 µg/ml, limit of quantification (LOQ) was 0.044 
µg/ml. 
LC-MS analysis
LC-MS measurement was performed using an LCQ 
Accela Fleet (Thermo Fisher Scientific, U.S.A) atmospheric 
pressure chemical ionization (APCI) and photodiode 
array detector. The column and gradient were the same 
as in the HPLC, but in the LC-MS mobile phase, formic 
acid was used instead phosphoric acid. APCI capillary 
temperature was 275 °C, APCI vaporizer temperature 
was 400 °C, sheath gas flow was 58 L/min, auxiliary gas 
flow was 10 L/min. The negative polarity source voltage 
was 6 kV, source current 10 μA, and capillary voltage -10 
V; for the positive polarity source, the voltage was 6 kV, 
source current 5 μA, and capillary voltage 43 V.
Chemicals
The standards of CBD, CBDA, CBGA were purchased 
from Sigma-Aldrich (Czech Republic); acetonitrile and 
methanol were purchased from Merck (Czech Republic), 
ethylacetate, formic and o-phosphoric acid from Fluka 
(Czech Republic). 
Statistical analysis
The basic calculations and statistical tools (MS Office 
Excel) were used for confirmation of linearity, calibration, 
and other calculations. The influence of year, variety, and 
plant part was evaluated by analysis of variance with the 
post hoc Tukey HSD test (Statistica 12.0).
RESULTS
The influence of hemp plant parts, sex and variety on 
the CBD level 
The cannabidiol level in the individual hemp plant parts 
were significantly different. The inflorescence parts had 
the highest CBD level (Table 2). According to Turner et al. 
(1980), hemp flowers (bracts) have the highest number 
of glands on their surface; therefore, the production of 
cannabinoids (and also CBD) was highest here. CBD levels 
in inflorescences is only influenced by the proportion of 
bracts and their age. In other plant parts, the CBD level 
decreased in the following order: leaves > seeds ≥ stems 
> roots. The CBD level in the leaves ranged from 16 to 
125 mg/kg DM. Similarly, Turner et al. (1980) found the 
CBD level from 10 to 80 mg/kg DM in leaflets less than 
5 cm long. Stems and roots had a low CBD level, or they 
were under the limit of detection (Table 2).
In the case of the dioecious variety, the influence 
of sex on the CBD level in the plant parts was evident 
(P<0.001). The female inflorescences reached 2x higher 
levels of CBD than the male inflorescences of the 'Finola' 
variety (Table 2). These results agree with Hemphill et al. 
(1980) who found that the pistillate plant parts contained 
from 0 to 2.79 mg/100g DM of CBD, and staminate 
plant parts from 0 to 1.48 mg/100g DM CBD. According 
to Ranali (1999), sexual differentiation is caused by a 
greater density of glands on bracts subtending the female 
flowers. The difference in the CBD level between stems 
of male and female plants was not possible to evaluate 
due to the low level of CBD (under the detection limit). 
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Table 2. The mean canabidiol level in C. sativa in mg/kg DM (mean ± standard deviation) in 2012
'Finola' 'Bialobrzeskie' Var. diff.
Roots 0.85±0.02a x
Leaves female plant 16.54±1.20b 56.71±4.66b ***
Stems, female plant x 4.27±0.39 a 
Stems, male plant x
Inflorescence, female plant 135.41±8.64d 262.92±10.57c ***
Inflorescences, male plant 61.82±17.34c ***
Seeds 14.80±0.32b 17.07±1.38a N.S
x – The CBD level under LOD; a-d: differences among plant parts after Tukey HSD test; n.s. - nonsignificant; ***, P<0.001; *, P<0.05
The influence of the hemp variety on the CBD level in 
both leaves and inflorescences was significant (P<0.001). 
Hillig and Mahlberg (2004) determined the CBD level 
in inflorescences of different hemp chemotypes, with 
an average of 3.8 ± 1.7% CBD found in varieties of 
chemotype II. Although both tested varieties belonged to 
chemotype II, the average CBD level in the inflorescences 
of the 'Bialobrzeskie' variety agree with the results of 
Hilling and Mahlberg (2004); however, the 'Finola' variety 
had a CBD level below this range (Table 2). The 'Finola' 
variety has been especially bred for seed production, so 
this selection could be the cause of the low CBD level. 
It follows that the varieties used have an important 
influence on CBD production. 
The environmental conditions influence on the the CBD 
level
Environmental conditions had an important influence 
on the CBD level. Differences between years were 
evident and statistically significant (P<0.001). Sikora et al. 
(2011) found that precipitation had a negative influence 
on the CBD level, and soil temperature at 5 cm had a 
positive effect on the CBD level as growing degree days. 
According to Pacifico et al. (2006), hemp plants grown in 
a dry place or during a dry season contained higher levels 
of cannabinoids, and CBD production decreased with 
increased temperature (32 °C). This agrees with results 
in this study; the growing season in 2014 was drier but 
cooler (Table 1), and the CBD level in the plants that year 
was higher compared with the 2012 growing season 
(Figure 1). Plants that exhibited water stress in 2014 were 
half of the height compared to plant height in 2012 (Table 
3). Ranalli (1999) noticed a negative correlation between 
plant height at harvest and THC level.  According to results 
of this study, the negative correlation between CBD level 
and plant height can also be applied to the CBD level. 
Solar irradiation, especially UV-B intensity, has an 
important influence on the CBD level. According to Lydon 
and Teramuta (1987), 1320 kJ/m2/day of UV and visible 
radiation caused chemical lability of CBD, with a gradual 
and consistent decline in the resin from floral tissues. In 
this experiment, the sum duration of sunshine for the 
growing period (V-IX) reached 938 h in 2012 and 625 h in 
2014. Thus, lower sunshine duration could be connected 
with a higher CBD level in hemp plants.
The next important influence on the CBD level after 
weather conditions is the soil mineral balance of the 
stand, especially the nitrogen, phosphorus, potassium, 
and calcium levels in the soil (Bocsa et al., 1997, Rannali, 
1999). However, in this study this influence was minimal 
due to very similar basic elemental contents in the soil at 
the experimental location in both years (see section Field 
experiment).
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Table 3. Production of dry matter and potential CBD production of two varieties of hemp (mean ± standard deviation)
Variety 'Bialobrzeskie' 'Finola' Var. diff.
Year 2012 2014 2012
Dry matter of leaves (t/ha) 1.5 ± 0.36A 0.9 ± 0.29A 1.2 ± 0.37 n.s
Dry matter of inflorescences (t/ha) 1.5 ± 0.42A 0.9 ± 0.31A 2.4 ± 0.56 n.s.
Total production of biomass dry matter (t/
ha) 12 ± 1.5B 5 ± 1.3A 6 ±1.2 *
Plant height (cm) 205 ± 23B 101 ± 18A 75 ±14 ***
CBD production in leaves (kg/ha) 84 ± 2.0B 112 ± 9.2A 19 ±1.5 ***
CBD production in inflorescences (kg/ha) 395 ± 1.1B 287 ± 11.5A 162 ±10.6 (female)74 ± 20.7 (male) ***
Total CBD production (kg/ha) 479 ± 1.9B 399 ± 8.4A 256 ± 10.9 *
A-B: differences among years after Tukey HSD test, n.s. - nonsignificant; ***, P<0.001; *, P<0.05
Figure 1. Interannual differences in the CBD level in different 
hemp parts of Bialobrzeskie variety (mean ± standard deviation). 
Different small letters (a - b) represent statistically significant 
differences (P <0.05) between the years in the plant part
Dominant cannabinoids and technics for increasing of 
the CBD level  
For medicinal use, the dominant contents of effective 
compounds of interest in the plant materials are important. 
Therefore, a cannabinoid profile is necessary to take into 
account when varieties are selected for CBD extraction. 
In this study, CBD was not the dominant constituent 
of the cannabinoids. The dominant compound in HPLC 
separation (UV spectrum, retention time) were the 
cannabidiolic (CBDA) and canabigerolic acids (CBGA).
Identification of these compounds was confirmed 
using LC-MS (CBDA [M-H]- 357, CBGA [M-H]- 359, 
CBD [M+H]+ 315). In this study, CBDA was dominant in 
inflorescences and leaves. The stems and seeds contained 
low levels, with the roots only containing traces of CBDA 
as well as CBGA and CBD (Tables 4 and 5). The influence 
of environmental conditions on the content of CBDA and 
CBGA were only significant in the case of CBDA content 
in the leaves (4267.18 x 6419.77 mg/kg DM). Varietal 
differences were significant in inflorescences for both 
acids, as well as in the leaves and stems in the case of 
CBDA.
According to Wang et al. (2016), it is possible to use 
CBDA after decarboxylation under the influence of heat 
(110 °C for 50 min) as a source of CBD, because CBD in 
Cannabis sativa L. is predominantly biosynthesized from 
CBDA. This fact can be used in CBD extraction, and after 
heating of the extracts it is possible to get more CBD than 
the plant material originally contained. Heating of the 
extracts at 50 °C for 180 min. increased the CBD level 
only 7.8 times, on average. CBDA and CBGA levels were 
almost unchanged (Table 6). However, heating of the 
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Table 4. The mean CBDA level in C. sativa in mg/kg DM (mean ± standard deviation) in 2012
Variety 'Finola' 'Bialobrzeskie' Var. diff.
Roots 7.9±0.20a 1.0±0.1a n.s
Leaves female plant 1792.1±27.26c 4267.18±64.80c *
Stems, female plant 125.1±2.50b
367.07±12.24b
*
Stems, male plant 30.4±0.04a ***
Inflorescence, female plant 8707.7±47.62e
11519.54±1544.17d
*
Inflorescence, male plant 4561.6±1.18d ***
Seeds 49.40±16.07ab 190.41±8.59b n.s
x – The CBDA level under LOD; a-d: differences among plant parts after Tukey HSD test; n.s. - nonsignificant; ***, P<0.001; *, P<0.05
Table 5. The mean CBGA level in C. sativa in mg/kg DM (mean ± standard deviation) in 2012
Variety 'Finola' 'Bialobrzeskie' Var. diff.
Roots 0.998±0,06a x
Leaves female plant 14.35±0.10a 17.00±1.20a n.s
Stems, female plant 9.49±0.50a
5.55±0.18a
n.s
Stems, male plant 2.35±0.16a n.s
Inflorescence, female plant 1345.43±1.26c
905.40±104.73b
***
Inflorescence, male plant 468.31±9.75b ***
Seeds 0.72±0.25a 5.25±0.23a n.s
x – The CBDA level under LOD; a-d: differences among plant parts after Tukey HSD test; n.s. - nonsignificant; ***, P<0.001; *, P<0.05
Table 6. The change of the CBD, CBDA, and CBGA content after heating of extracts from hemp materials in 2012 (in % of the 
initial content)
CBDA CBGA CBD
Temperature (°C) /time of heating (min) 50/180 145/15 50/180 145/15 50/180 145/15
'Bialobrzeskie' leaves 108.9 3.4 56.6 x 1054.5 4428.6
'Bialobrzeskie' inflorescences 119.1 1.0 114.6 x 846.3 3788.2
'Finola' leaves female plant 89.2 0 x x 223.3 2439.9
'Finola' female inflorescences 116.0 8.7 118.3 10.1 996.0 6173.5
x- The content after heating under the limit of detection
extracts at 145 °C for 15 min. increased the CBD level 42 
times, on average (Table 6).The highest content of CBD 
(13 459 mg/kg DM) was determined in the extract of the 
'Bialobrzeskie' variety from inflorescences.
The theoretical CBD production 
A variety suitable for CBD production should have 
a good yield of leaves and inflorescences (in dry matter 
per unit area). The 'Finola' variety reached a lower height 
(Table 3) and total yield of biomass, but its advantage 
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is the high proportion of inflorescence dry matter and 
its fast development; female plants started to flower 
37 days after sowing. However, the lower CBD level in 
the plant parts also caused lower CBD production from 
green biomass per unit area (Table 3). The 'Bialobrzeskie' 
variety had a high total biomass yield (12 t/ha) and high 
CBD production in both leaves and inflorescences, but 
the proportion of inflorescence dry matter is low (30% 
proportion of leaves and inflorescences out of total 
biomass for 'Bialobrzeskie'; 60% for 'Finola'). The mean 
CBD production in the leaves and inflorescence dry 
matter harvested at the flowering stage was 440 kg/ha. 
According to Mueller (2014), it is possible to extract up to 
90% of the contained CBD from industrial hemp. From this 
point of view, the 'Bialobrzeskie' variety could be suitable 
for CBD extraction not only for its higher CBD content 
but also for its higher CBGA and CBDA levels. So, this 
variety is justifiedly considered as a variety of combined 
efficiency. Hemp plants harvested at the flowering stage 
could have the inflorescences with leaves (top of the 
plants) pulled off from the stems for CBD extraction, and 
the stems used for fiber production. 
The CBD level in the seeds is determined by resin 
production in any given year that sticks on the seed 
surface. So, a possible source of CBD could also be the 
hulls, the waste after hulling of the hemp seeds. The seed 
coat consists of about 35±7% of the total weight of the 
seed. Based on this data, the mean yield of hulls in this 
study reached 0.14 t/ha (Table 7). Thus, the CBD, CBDA, 
and CBGA production in the seeds is considerably lower 
(5.6 g/ha on average), compared with production in the 
leaves and inflorescences. 
CONCLUSIONS 
It is possible to conclude that for CBD extraction, it is 
possible to utilize the raw materials of suitable varieties 
bred for fiber production. Industrial hemp harvested 
at the flowering stage could produce material for CBD 
extraction as well as for fiber production from extraction. 
A significant increase in CBD content is achieved by 
heating extracts from the hemp materials.
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